Dimensional Fund Advisors LP Verrica Pharmaceuticals Inc. Transaction History

Dimensional Fund Advisors LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	SELL	$2.93 - $7.32 $15,590 - $38,949	-5,321 Reduced 31.35%	11,654 $85,000
Q3 2023 Nov 09, 2023	BUY	$3.75 - $7.46 $30 - $59	8 Added 0.05%	16,975 $65,000
Q1 2023 May 12, 2023	BUY	$2.88 - $8.51 $48,864 - $144,389	16,967 New	16,967 $110,000
Q2 2022 Aug 12, 2022	SELL	$1.81 - $8.93 $11,989 - $59,152	-6,624 Reduced 20.18%	26,193 $50,000
Q1 2022 May 13, 2022	BUY	$7.59 - $9.49 $78,085 - $97,633	10,288 Added 45.67%	32,817 $266,000
Q4 2021 Feb 09, 2022	BUY	$9.1 - $13.36 $9,718 - $14,268	1,068 Added 4.98%	22,529 $206,000
Q2 2021 Aug 12, 2021	BUY	$9.77 - $15.33 $209,673 - $328,997	21,461 New	21,461 $243,000

17.5M

6.1K

6.3K

Ticker VRCA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,094,100
Market Cap $327M
Description
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.